By Giulia PetroniNovartis said Monday that its generics unit Sandoz has appointed a new board of directors ahead of the planned spinoff and listing on the Swiss stock exchange. The Swiss pharma major said Sandoz's board will count 10 members and three sub-committees, namely innovation and development, human capital and ESG, and audit, risk and compliance. It will be effective after the spinoff in the second half of the year.

Source: Wall Street Journal May 15, 2023 05:40 UTC